The effect of β-cyclodextrin complexation on the bioavailability and hepatotoxicity of clotrimazole

Pharmazie

Volumn 62, Issue 10, 2007, Pages 756-759

  Yong, C S ^a   Li, D X ^c   Prabagar, B ^a   Park, B C ^a   Yi, S J ^b   Yoo, B K ^a   Lyoo, W S ^a   Woo, J S ^a   Rhee, J D ^a   Kim, Jung Ae ^a   Choi, Han Gon ^a  

^a Yeungnam University   (South Korea)

^b Kyungpook National University   (South Korea)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA CYCLODEXTRIN; CLOTRIMAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CANCER; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; HYPERTROPHY; LIVER SINUSOID; LIVER TOXICITY; MALE; NONHUMAN; RAT; SICKLE CELL ANEMIA;

ALANINE TRANSAMINASE; ANIMALS; ANTIFUNGAL AGENTS; AREA UNDER CURVE; ASPARTATE AMINOTRANSFERASES; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; CLOTRIMAZOLE; DRUG CARRIERS; HALF-LIFE; HEPATITIS, TOXIC; LIVER; LIVER FUNCTION TESTS; MALE; MICE; MICE, INBRED ICR; POWDERS; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 35348956337     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.10.7018     Document Type: Article

References (21)

1. Becket G, Schep LJ, Tan MY (1999) Improvement of the in vitro dissolution of praziquantel by complexation with α-, β-, and γ-cyclodextrins. Int J Pharm 179: 65-71.
2. Bekers O, Uijtendaal EV, Beijnen JH, Bult, A, Underberg WJM (1991) Cyclodextrins in the pharmaceutical field. Drug Dev Ind Pharm 17: 1503-1549.
3. Chang JY, Oh YK, Kong HS, Kim EJ, Jang DD, Nam KT, Kim CK (2002) Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release 82: 39-50.
4. Choi HG, Lee BJ, Yong CS, Rhee JD, Han JH, Lee MK, Park KM, Kim CK (2001) Terfenadine-β-cyclodextrin inclusion complex with the anti-histaminic activity enhancement. Drug Dev Ind Pharm 27: 857-862.
5. Coe KJ, Nelson SD, Ulrich RG, He Y, Dai X, Cheng O, Caguyong M, Roberts CJ, Slatter JG (2006) Profiling the hepatic effects of flutamide in rats: a microarray comparison with classical aryl hydrocarbon receptor ligands and atypical CYP1A inducers. Drug Metab Dispo 34: 1266-1275.
6. Ficarra R, Ficarra P, Di Bella MR, Raneri D, Tommasini S, Calabrò ML, Villari A, Coppolino S (2000) Study of the inclusion complex of atenolol with β-cyclodextrin. J Pharm Biomed Anal 23: 231-236.
7. Gandhi RB, Karara AH (1988) Characterization, dissolution and diffusion properties of tolbutamide-β-cyclodextrin complex system. Drug Dev Ind Pharm 14: 657-682.
8. Jarvinen T, Jarvinen K, Schwarting N, Stella VJ (1995) β-Cyclodextrin derivatives, SBE4-β-CD and HP-β-CD, increase the oral bioavailability of cinnarizine in beagle dogs. J Pharm Sci 84: 295-299.
9. Kimura E, Bersani-Amado CA, Sudo SU, Santos SRJ, Oga S (1997) Pharmacokinetic profile of piroxicam-β-cyclodextrin, in rat plasma and lymph. General Pharmacol 28: 695-698.
10. Lee SW, Kim MH, Kim CK (1999) Encapsulation of ethanol by spray drying technique: effects of sodium lauryl sulfate. Int J Pharm 187: 193-198.
11. Miranda CL, Henderson MC, Buhler DR (1998) Evaluation of chemicals as inhibitors of trout cytochrome P450s. Toxicol Appl Pharmacol 148: 237-244.
12. Nakai Y, Yamamoto K, Terada K., Akimoto K. (1984) The dispersed states of medicinal molecules in ground mixtures with α-or β-cyclodextrin. Chem Pharm Bull 32: 685-691.
13. Ning M, Gu Z, Pan H, Yu H, Xiao K (2005) Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole. Indian J Exp Biol 43: 150-157.
14. Pedersen M, Bjerregaard S, Jacobsen J., Sørensen AM (1998) A genuine clotrimazole γ-cyclodextrin inclusion complex-isolation, antimycotic activity, toxicity and an unusual dissolution rate. Int J Pharm 176: 121-131.
15. Pedersen M (1993) Effect of hydrotropic substances on the complexation of clotrimazole with b-cyclodextrin. Drug Dev Ind Pharm 19: 439-448.
16. Pedersen M (1997) The bioavailability difference between genuine cyclodextrin inclusion complexes and freeze-dried or ground drug cyclodextrin samples may be due to supersaturation differences. Drug Dev Ind Pharm 23: 331-335.
17. Stella VJ, Rajewski RA (1997) Cyclodextrins: their future in drug formulation and delivery. Pharm Res 14: 556-567.
18. Stuchal LD, Kleinow KM, Stegeman JJ, James MO (2006) Demethylation of the pesticide methoxychlor in liver and intestine from untreated, methoxychlor-treated, and 3-methylcholanthrene-treated channel catfish (Ictalurus punctatus): evidence for roles of CYP1 and CYP3A family isozymes. Drug Metab Dispos 34: 932-938.
19. Wojtulewski JA, Gow PJ, Walter J, Grahame R, Gibson T, Panayi GS, Mason J (1980) Anti-inflammatory effect of clotrimazole. Ann Rheum 39: 469-472.
20. Wong JW, Yuen KH (2001) Improved oral bioavailability of artemisinin through inclusion complexation with β- and γ-cyclodextrin. Int J Pharm 227: 177-185.
21. Yun MO, Choi HG, Jung JH, Kim CK (1999) Development of thermoreversible insulin liquid suppository with sodium salicylate. Int J Pharm 189: 137-145.